The United States develops 100% immunization against malaria

The American Journal of Science (Science) has just published the results of a phase study of a malaria vaccine clinical trial, an important step in the ability to prepare a vaccine to prevent a relatively common disease. variable in tropical countries, including Vietnam.

According to the magazine, out of 40 people aged 20 to 44 who participated in the trial, 9 adults were vaccinated with the strongest dose, 6 were 100% protected.

Photo: womenworld.org

However, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) of the United States, said that the number of people participating in clinical trials is small and needs to prove that immunity is Sustainable and effective properties for many different variants of malaria parasites.

The anti-malaria vaccine, co-produced by the Sanaria and NIAID pharmaceutical companies, is prepared from the parasite "Plasmodium falciparum" and is being studied in the first stage.

With this extremely positive result, the research is continuing to expand and clinical trials on children will be conducted in some African countries, where the rate of malaria infection is highest. world.

However, according to scientists who have to wait at least 10 years, the vaccine against malaria can be widely used, because the development of a new vaccine is always a long and complicated process.

Currently, the world has not prepared any vaccines that can fight parasitic diseases. Malaria is the cause of death for more than 700,000 people worldwide each year.